Jakafi – Blood Cancer – Nov Display Banners HCP Wallboard Extension – 26346

Cognitive function following cancer and cancer treatment has been an area of accelerated research over the last 20-30 years, explains Zev Nakamura, MD. “Most recently, there has been increasing appreciation of the importance of...

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40%, according to a study presented at the 2022 annual meeting of the...

World Trade Center (WTC)-exposed rescue/recovery workers have an increased risk for the myeloma precursor disease monoclonal gammopathy of undetermined significance (MGUS), according to a study published in Blood Cancer Journal....

During a recent PW podcast episode, Gita Thanarajasingam, MD, a hematologist and researcher at Mayo Clinic, talked about the assessment and reporting of adverse events in treatments for chronic myeloid leukemia (CML). The...

Patients with typical tumefactive demyelinating lesions (TDLs) have younger age of onset than those with sentinel lesions of primary central nervous system lymphoma (PCNSL), and hypodense lesions are seen on computed tomography...

Novel coding and noncoding gene variants have been identified that may increase the risk for developing Hodgkin lymphoma (HL), according to a study published in Blood. Jamie E. Flerlage, MD, MS, and colleagues performed...